Drugs for Elevated Low-Density Lipoprotein Cholesterol

Mar 21, 2019 by in GENERAL Comments Off on Drugs for Elevated Low-Density Lipoprotein Cholesterol

Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, also known as statins, are competitive inhibitors of the rate-limiting step of hepatic cholesterol synthesis. This leads to a reduction in hepatocyte cholesterol…

read more

Atrial Fibrillation

Mar 21, 2019 by in GENERAL Comments Off on Atrial Fibrillation

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, and in many ways it is the most complex to manage. Understanding of this disorder has increased immensely in…

read more

Pharmacologic Management of Supraventricular Tachycardias

Mar 21, 2019 by in GENERAL Comments Off on Pharmacologic Management of Supraventricular Tachycardias

Electrophysiologic study with catheter ablation is now the primary mode of therapy for most forms of recurrent supraventricular tachycardia. However, pharmacologic therapy for acute episodes and for the long-term management…

read more

Clinical Pharmacology of Antiarrhythmic Drugs

Mar 21, 2019 by in GENERAL Comments Off on Clinical Pharmacology of Antiarrhythmic Drugs

Antiarrhythmic drugs were developed with the expectation that they would extend and improve life for many patients with cardiovascular (CV) disease and those with a history of life-threatening arrhythmias. The…

read more

Regenerative Therapy for Heart Failure

Mar 21, 2019 by in GENERAL Comments Off on Regenerative Therapy for Heart Failure

This chapter discusses the fundamental observations that have profoundly changed our view of the adult human heart, resulting in the experimental use of stem/progenitor cells as a potential form of…

read more

Cardiac Transplantation and Circulatory Support Devices

Mar 21, 2019 by in GENERAL Comments Off on Cardiac Transplantation and Circulatory Support Devices

Overview Despite treatment with new drug regimens and high-risk cardiac surgery, many patients with heart failure (HF) progress to advanced stages characterized by marked symptomatic limitation and profound hemodynamic compromise….

read more

ST-Segment Elevation Myocardial Infarction

Mar 21, 2019 by in GENERAL Comments Off on ST-Segment Elevation Myocardial Infarction

Overview ST-segment elevation myocardial infarction (STEMI) is a significant health problem in industrialized countries and is becoming an increasingly significant problem in developing countries. STEMI is a clinical syndrome defined…

read more
Premium Wordpress Themes by UFO Themes